Intrinsiqs

Is Abbott Laboratories overvalued?

Abbott Laboratories (ABT) looks overvalued — trading about 60% above its fair value.

Overvalued
Current price $101.30 Fair value $40.45
Price
$101.30
Fair value
$40.45
Current P/E
27.2
Normal P/E
10.9
Market cap
$175.29B
Dividend yield
2.4%
Return on equity
10.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ABT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated